Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndrome

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 8, 2008, Pages 612-617

  Mussai, Francis J ^a   Cunningham, Lea C ^a   Rezvani, Geoffrey ^b   Stratakis, Constantine A ^b   Reynolds, James C ^c   Nesterova, Galina ^d   Henshaw, Robert M ^e   Levine, Jason E ^a   Helman, Lee J ^a   Arthur, Diane C ^f   Kim, Su Young ^a,b  

^a Pediatric Oncology Branch   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d CLINICAL CENTER   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

22q11.2 deletion syndrome; Hypocalcemia; Osteosarcoma

Indexed keywords

CALCITRIOL; CALCIUM; CISPLATIN; COLECALCIFEROL; DOXORUBICIN; GLUCONATE CALCIUM; METHOTREXATE;

ADD ON THERAPY; ADOLESCENT; ARM AMPUTATION; ARTICLE; BONE METASTASIS; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM URINE LEVEL; CASE REPORT; CHROMOSOME 22Q; CYTOGENETICS; GENE DELETION; HUMAN; HUMAN TISSUE; HUMERUS; HYPOCALCEMIA; LABORATORY TEST; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR BIOPSY; AMPUTATION; BONE TUMOR; DIGEORGE SYNDROME; IN SITU HYBRIDIZATION; PATHOLOGY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; AMPUTATION; BONE NEOPLASMS; DIGEORGE SYNDROME; HUMANS; HUMERUS; HYPOCALCEMIA; IN SITU HYBRIDIZATION; MALE; OSTEOSARCOMA;

EID: 53749096268     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318168f072     Document Type: Article

References (13)

1. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-790.
2. Raskin P, McClain CJ, Medsger TA. Hypocalcemia associated with metastatic bone disease. Arch Intern Med. 1973;132:539-543.
3. Mahoney JP, Spanier SS, Morris JL. Multifocal osteosarcoma: a case report with review of the literature. Cancer. 1979;44:1897-1907.
4. Chap LI, Mirra J, Ippolito V, et al. Miliary osteosarcomatosis with associated hypocalcemia. Am J Clin Oncol. 1997;20:505-508.
5. Gunawardena S, Chintagumpala M, Trautwein L, et al. Multifocal osteosarcoma: an unusual presentation. J Pediatr Hematol Oncol. 1999; 21:58-62.
6. Soltani A, Hasani-Ranjbar S, Moayyeri A. Hypocalcemia as a presentation for multifocal osteosarcoma. Pediatr Blood Cancer.2007; ahead of print.
7. Sullivan KE. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol. 2004;4:505-512.
8. Bachrach LK, Hastie T, Wang MC, et al. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. J Clin Endocrinol Metab. 1999;84:4702-4712.
9. Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2003;21:2011-2018.
10. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112: 101-107.
11. Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res. 2005;63: 294-299.
12. Bridge JA, Nelson M, McComb E, et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genet Cytogenet. 1997;95:74-87.
13. Miller CW, Ikezoe T, Krug U, et al. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors. Genes Chromosomes Cancer. 2002;33:17-21.